VAMED, a leading global provider of services for hospitals and other healthcare facilities, today announced that it has entered into an agreement to sell the majority of its post-acute care business (in particular the rehabilitation business) to PAI Partners (‘PAI’). Closing is expected in the second half of 2024, subject to regulatory approval and the customary closing conditions. PAI will become the majority owner with 67 percent of the business, which will be combined in a new independent company under the PAI umbrella. Fresenius, the majority shareholder of VAMED, will own 33 percent of the new company.

Klaus Schuster, Spokesman of the Executive Board of VAMED: ‘Under PAI's umbrella, we see a promising future for VAMED's post-acute care business, which currently operates in five European countries. As a standalone company we will be able to focus fully on the future development of this business segment.’

As majority shareholder, PAI will drive the business forward, continuing to put service orientation, best medical outcomes and positioning as an attractive place to work for employees at the forefront.

PAI is an international private equity firm based in France that invests in market-leading companies worldwide. It has significant experience in the healthcare sector. As a standalone business, the post-acute care business will benefit from PAI's extensive healthcare expertise, such as Veonet, the leading pan-European network of eye clinics.

The post-acute care business comprises 67 facilities with 9,100 beds and around 9,500 employees (FTE) across Germany, Austria, Switzerland, the Czech Republic, and the UK. The unit provides a comprehensive range of rehabilitation services, as well as acute care and nursing.